These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 27458056)
1. Suppression of TWIST1 enhances the sensitivity of colon cancer cells to 5-fluorouracil. Sakowicz-Burkiewicz M; Przybyla T; Wesserling M; Bielarczyk H; Maciejewska I; Pawelczyk T Int J Biochem Cell Biol; 2016 Sep; 78():268-278. PubMed ID: 27458056 [TBL] [Abstract][Full Text] [Related]
2. The Level of Przybyla T; Wesserling M; Sakowicz-Burkiewicz M; Maciejewska I; Pawelczyk T Saudi J Gastroenterol; 2018; 24(1):37-45. PubMed ID: 29451183 [TBL] [Abstract][Full Text] [Related]
3. Suppression of ID1 expression in colon cancer cells increases sensitivity to 5-fluorouracil. Przybyła T; Sakowicz-Burkiewicz M; Maciejewska I; Bielarczyk H; Pawełczyk T Acta Biochim Pol; 2017; 64(2):315-322. PubMed ID: 28510612 [TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer. Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611 [TBL] [Abstract][Full Text] [Related]
5. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer. Ahn JY; Lee JS; Min HY; Lee HY Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450 [TBL] [Abstract][Full Text] [Related]
6. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233 [TBL] [Abstract][Full Text] [Related]
7. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression. Findlay VJ; Wang C; Nogueira LM; Hurst K; Quirk D; Ethier SP; Staveley O'Carroll KF; Watson DK; Camp ER Mol Cancer Ther; 2014 Nov; 13(11):2713-26. PubMed ID: 25249558 [TBL] [Abstract][Full Text] [Related]
8. Conditioned media from human macrophages of M1 phenotype attenuate the cytotoxic effect of 5‑fluorouracil on the HT‑29 colon cancer cell line. Hedbrant A; Erlandsson A; Delbro D; Wijkander J Int J Oncol; 2015 Jan; 46(1):37-46. PubMed ID: 25310018 [TBL] [Abstract][Full Text] [Related]
9. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer. Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769 [TBL] [Abstract][Full Text] [Related]
10. Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells. Yang D; Qu J; Qu X; Cao Y; Xu L; Hou K; Feng W; Liu Y Cancer Chemother Pharmacol; 2015 Sep; 76(3):575-86. PubMed ID: 26208739 [TBL] [Abstract][Full Text] [Related]
11. Enhanced TLR4 Expression on Colon Cancer Cells After Chemotherapy Promotes Cell Survival and Epithelial-Mesenchymal Transition Through Phosphorylation of GSK3β. Chung YH; Kim D Anticancer Res; 2016 Jul; 36(7):3383-94. PubMed ID: 27354597 [TBL] [Abstract][Full Text] [Related]
12. Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro. Deng J; Lei W; Fu JC; Zhang L; Li JH; Xiong JP Biochem Biophys Res Commun; 2014 Jan; 443(3):789-95. PubMed ID: 24275137 [TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718 [TBL] [Abstract][Full Text] [Related]
14. Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells. Sousa-Squiavinato ACM; Arregui Ramos DA; Wagner MS; Tessmann JW; de-Freitas-Junior JCM; Morgado-Díaz JA Eur J Pharmacol; 2022 Oct; 933():175253. PubMed ID: 36067803 [TBL] [Abstract][Full Text] [Related]
15. EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells. Han M; Xu W Tumour Biol; 2017 Jul; 39(7):1010428317718404. PubMed ID: 28718375 [TBL] [Abstract][Full Text] [Related]
16. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis. Touil Y; Igoudjil W; Corvaisier M; Dessein AF; Vandomme J; Monté D; Stechly L; Skrypek N; Langlois C; Grard G; Millet G; Leteurtre E; Dumont P; Truant S; Pruvot FR; Hebbar M; Fan F; Ellis LM; Formstecher P; Van Seuningen I; Gespach C; Polakowska R; Huet G Clin Cancer Res; 2014 Feb; 20(4):837-46. PubMed ID: 24323901 [TBL] [Abstract][Full Text] [Related]
17. Selective protection by uridine of growth inhibition by 5-fluorouracil (5FU) mediated by 5FU incorporation into RNA, but not the thymidylate synthase mediated growth inhibition by 5FU-leucovorin. Codacci-Pisanelli G; Noordhuis P; van der Wilt CL; Peters GJ Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):733-9. PubMed ID: 18600533 [TBL] [Abstract][Full Text] [Related]
18. E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity. Druzhkova I; Ignatova N; Prodanets N; Kiselev N; Zhukov I; Shirmanova M; Zagainov V; Zagaynova E Clin Colorectal Cancer; 2019 Mar; 18(1):e74-e86. PubMed ID: 30415989 [TBL] [Abstract][Full Text] [Related]
19. Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells. Jiang D; Li J; Li J; Wang M; Han C; Wang X; Zhao C; Ye Y Int J Oncol; 2017 Nov; 51(5):1611-1620. PubMed ID: 29048661 [TBL] [Abstract][Full Text] [Related]
20. Protein-bound polysaccharide-K augments the anticancer effect of fluoropyrimidine derivatives possibly by lowering dihydropyrimidine dehydrogenase expression in gastrointestinal cancers. Mekata E; Murata S; Sonoda H; Shimizu T; Umeda T; Shiomi H; Naka S; Yamamoto H; Abe H; Edamatsu T; Fujieda A; Fujioka M; Wada T; Tani T Oncol Rep; 2013 Dec; 30(6):2845-51. PubMed ID: 24100378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]